![ACR abstract preview ACR abstract preview](/sites/novartis_com/files/styles/cta_image/public/2021-10/acr-abstract-measure-1.jpg.webp?itok=V6W67O24)
Secukinumab effect on the severity of ankylosing spondylitis after 5 years
A simplified overview of the abstract presented November 6, 2020.
![ACR abstract preview ACR abstract preview](/sites/novartis_com/files/styles/cta_image/public/2021-10/acr-abstract-maximise-2.jpg.webp?itok=dhKLiNkm)
Secukinumab as a treatment for psoriatic arthritis predominantly affecting the joints of the back and neck (axial joints)
A simplified overview of the abstract presented November 6, 2020.
![ACR abstract preview ACR abstract preview](/sites/novartis_com/files/styles/cta_image/public/2021-10/acr-abstract-ultimate-3.jpg.webp?itok=FYEngJ-r)
Using sensitive ultrasound imaging to understand speed of secukinumab response in psoriatic arthritis
A simplified overview of the abstract presented November 8, 2020.
![ACR abstract preview ACR abstract preview](/sites/novartis_com/files/styles/cta_image/public/2021-10/acr-abstract-machine-learning-4.jpg.webp?itok=PDa84Y6C)
Using machine learning to predict likelihood of achieving relief from psoriatic arthritis
A simplified overview of the abstract presented November 9, 2020.